Action on Fistula Wins Excellence in Corporate Social Responsibility Award

Fistula Foundation board member Denis Robson (second from right), celebrates the recent
Communiqué award with Astellas Pharma Communications team members Bily Kuo, Jo Taylor,
Christina Chale, and Ash Andrews, and Foster Communications CEO Amanda Powell Smith.
Each year at the Communiqué Awards, industry experts in the United Kingdom gather to celebrate the best of the best in healthcare communications. Professionals from advocacy, pharma, professional services and more come together to select their winners—and this year we were honored to be named among the showcased projects.
On July 6th, Fistula Foundation’s collaboration with Astellas Pharma EMEA was awarded the Excellence in Corporate Social Responsibility award. The prize honored our work with Astellas to create the Action on Fistula program—a groundbreaking, nationwide treatment network with the capacity to end fistula in Kenya. Our board member, Denis Robson, represented Fistula Foundation at the ceremony.
Judge’s Comments: “The Action on Fistula work was… extremely bold, ambitious and impressive… [they] stepped in to address an unmet need, demonstrating a tremendous improvement year on year for this massive and stigmatised disease.” — Communiqué Awards judges

Fistula Foundation board member Denis Robson (second from right), celebrates the recent Communiqué award with Astellas Pharma Communications team members Bily Kuo, Jo Taylor, Christina Chale, and Ash Andrews, and Foster Communications CEO Amanda Powell Smith. Photo courtesy of PMGroup

This story originally appeared in the Fall 2017 edition of our newsletter, Transformations.

Tags: , ,